litlas
Log inCreate account

Harald Holte

Active 1987–2025

78
Papers
23,975
Citations
48
h-index
67
i10-index

Citations

Citations per year for Harald Holte1979: 1 citations1988: 2 citations1989: 2 citations1990: 4 citations1991: 5 citations1992: 5 citations1993: 2 citations1994: 1 citations1995: 3 citations1996: 4 citations1997: 2 citations1998: 3 citations1999: 11 citations2000: 13 citations2001: 9 citations2002: 33 citations2003: 94 citations2004: 110 citations2005: 178 citations2006: 164 citations2007: 188 citations2008: 187 citations2009: 201 citations2010: 229 citations2011: 216 citations2012: 218 citations2013: 180 citations2014: 181 citations2015: 155 citations2016: 124 citations2017: 115 citations2018: 105 citations2019: 532 citations2020: 724 citations2021: 758 citations2022: 742 citations2023: 512 citations2024: 801 citations2025: 369 citations2026: 8 citations1980–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,943 citing papers, 28% of this breakdownGermany: 819 citing papers, 7.8% of this breakdownChina: 716 citing papers, 6.8% of this breakdownUnited Kingdom: 614 citing papers, 5.8% of this breakdownFrance: 577 citing papers, 5.5% of this breakdownItaly: 530 citing papers, 5% of this breakdownSpain: 490 citing papers, 4.7% of this breakdownCanada: 432 citing papers, 4.1% of this breakdownSwitzerland: 331 citing papers, 3.1% of this breakdownNetherlands: 256 citing papers, 2.4% of this breakdownAustralia: 255 citing papers, 2.4% of this breakdownJapan: 210 citing papers, 2% of this breakdown
0%28%Other 22.4%

Institutions

Fields

  • Medicine78.3%
  • Biochemistry, Genetics and Molecular Biology13.1%
  • Immunology and Microbiology4.9%
  • Mathematics1.4%
  • Computer Science1.1%
  • Engineering0.3%
  • Other0.9%

Topics

  • Lymphoma Diagnosis and Treatment15.4%
  • CAR-T cell therapy research13.7%
  • Immune Cell Function and Interaction4.1%
  • Chronic Lymphocytic Leukemia Research3.9%
  • CNS Lymphoma Diagnosis and Treatment3.5%
  • Viral-associated cancers and disorders3.4%
  • Other56%

Coauthors

All papers

Open in search
  1. Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Authors: Stephen J. Schuster, Michael Bishop, Constantine S. Tam, Edmund K. Waller, Peter Borchmann, Joseph P. McGuirk, Ulrich Jäger, Samantha Jaglowski, Charalambos Andreadis, Jason R. Westin, Isabelle Fleury, Veronika Bachanová, S.R. Foley, P. Joy Ho, Stephan Mielke, John Magenau, Harald Holte, Serafino Pantano, Lida Pacaud, Rakesh Awasthi, Jufen Chu, Özlem Anak, Gilles Salles, Richard T. Maziarz - New England Journal of Medicine 2018 cited by 4,044

  2. Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study

    Authors: Stephen J. Schuster, Constantine S. Tam, Peter Borchmann, Nina Worel, Joseph P. McGuirk, Harald Holte, Edmund K. Waller, Samantha Jaglowski, Michael Bishop, Lloyd E. Damon, S.R. Foley, Jason R. Westin, Isabelle Fleury, P. Joy Ho, Stephan Mielke, Takanori Teshima, Murali Janakiram, Jing-Mei Hsu, Koji Izutsu, Marie José Kersten, Monalisa Ghosh, Nina D. Wagner‐Johnston, Koji Kato, Paolo Corradini, Marcela Martínez-Prieto, Xia Han, Ranjan Tiwari, Gilles Salles, Richard T. Maziarz - The Lancet Oncology 2021 cited by 561

  3. Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma

    Authors: Michael R. Bishop, Michael Dickinson, Duncan Purtill, Pere Barba, Armando Santoro, Nada Hamad, Koji Kato, Anna Sureda, Richard Greil, Catherine Thieblemont, Franck Morschhauser, Martin Janz, Ian W. Flinn, Werner Rabitsch, Yok‐Lam Kwong, Marie José Kersten, Monique C. Minnema, Harald Holte, Esther Hian Li Chan, Joaquín Martínez‐López, Antonia Müller, Richard T. Maziarz, Joseph P. McGuirk, Emmanuel Bachy, Steven Le Gouill, Martin Dreyling, Hideo Harigae, David A. Bond, Charalambos Andreadis, Peter A. McSweeney, Mohamed A. Kharfan‐Dabaja, Simon Newsome, Evgeny Degtyarev, Rakesh Awasthi, Christopher del Corral, Giovanna Andreola, Aisha Masood, Stephen J. Schuster, Ulrich Jäger, Peter Borchmann, Jason R. Westin - New England Journal of Medicine 2021 cited by 520

  4. Stromal Gene Signatures in Large-B-Cell Lymphomas

    Authors: Georg Lenz, George W. Wright, Sandeep S. Davé, Wenming Xiao, John Powell, Hong Zhao, Weihong Xu, Bruce K. Tan, Neta Goldschmidt, Javeed Iqbal, Julie Vose, M. Bast, Kai Fu, DD Weisenburger, Timothy C. Greiner, Jamés O. Armitage, Alastair H. Kyle, Lorraine F. May, Randy D. Gascoyne, Joseph M. Connors, Gunhild Trøen, Harald Holte, Stein Kvaløy, Daan Dierickx, G. Verhoef, Jan Delabie, Erlend B. Smeland, Pedro Jares, Antonio Martı́nez, Armando López‐Guillermo, Emili Montserrat, Elı́as Campo, Rita M. Braziel, Thomas P. Miller, Lisa M. Rimsza, James R. Cook, Brad Pohlman, John Sweetenham, Raymond R. Tubbs, Richard I. Fisher, Elena Hartmann, Andreas Rosenwald, German Ott, Müller-Hermelink Hk, David Wrench, T. Lister, Elaine S. Jaffe, Wyndham H. Wilson, Wing C. Chan, Louis M. Staudt - New England Journal of Medicine 2008 cited by 1,818

  5. The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

    Authors: Andreas Rosenwald, George W. Wright, Wing C. Chan, Joseph M. Connors, Elı́as Campo, Richard I. Fisher, Randy D. Gascoyne, H. K. Müller-Hermelink, Erlend B. Smeland, Jena M. Giltnane, Elaine M. Hurt, Hong Zhao, Lauren Averett, Liming Yang, Wyndham H. Wilson, Elaine S. Jaffe, Richard H. Simon, Richard D. Klausner, John Powell, P L Duffey, Dan L. Longo, Timothy C. Greiner, Dennis D. Weisenburger, Warren G. Sanger, Bhavana J. Davé, James C. Lynch, Julie M. Vose, Jamés O. Armitage, Emilio Montserrat, Armando López‐Guillermo, Thomas M. Grogan, Thomas P. Miller, M. Leblanc, German Ott, Stein Kvaløy, Jan Delabie, Harald Holte, Peter Krajči, Trond Stokke, Louis M. Staudt - New England Journal of Medicine 2002 cited by 3,859

  6. Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma

    Authors: Leo Meriranta, Amjad Alkodsi, Annika Pasanen, Maija Lepistö, Parisa Mapar, Yngvild Nuvin Blaker, Judit Jørgensen, Marja‐Liisa Karjalainen‐Lindsberg, Idun Fiskvik, Lars Tore Gyland Mikalsen, Matias Autio, Magnus Björkholm, Mats Jerkeman, Øystein Fluge, Peter de Nully Brown, Sirkku Jyrkkiö, Harald Holte, Esa Pitkänen, Pekka Ellonen, Sirpa Leppä - Blood 2021 cited by 129

  7. A Prognostic Score for Advanced Hodgkin's Disease

    Authors: Dirk Hasenclever, Volker Diehl, Jamés O. Armitage, David Assouline, Magnus Björkholm, Ercole Brusamolino, George P. Canellos, Patrice Carde, Derek Crowther, David Cunningham, Houchingue Eghbali, Christophe Ferm�, Richard I. Fisher, John H. Glick, Bengt Glimelius, Paolo G. Gobbi, Harald Holte, Sandra J. Horning, Tim Lister, Dan L. Longo, Franco Mandelli, Aaron Polliack, Stephen J. Proctor, Lena Specht, John Sweetenham, G. Vaughan Hudson - New England Journal of Medicine 1998 cited by 1,733

  8. Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma

    Authors: Matias Autio, Suvi‐Katri Leivonen, Oscar Brück, Satu Mustjoki, Judit Jørgensen, Marja‐Liisa Karjalainen‐Lindsberg, Klaus Beiske, Harald Holte, Teijo Pellinen, Sirpa Leppä - Haematologica 2020 cited by 162

  9. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

    Authors: Viola Poeschel, Gerhard Held, Marita Ziepert, Mathias Witzens‐Harig, Harald Holte, Lorenz Thurner, Peter Borchmann, Andreas Viardot, Martin Soekler, Ulrich Keller, Christian Schmidt, Lorenz Truemper, Rolf Mahlberg, Reinhard Marks, Heinz‐Gert Hoeffkes, Bernd Metzner, Judith Dierlamm, Norbert Frickhofen, Mathias Haenel, Andreas Neubauer, Michael Kneba, Francesco Merli, Alessandra Tucci, Peter de Nully Brown, Massimo Federico, Eva Lengfelder, Alice Di Rocco, Ralf Ulrich Trappe, Andreas Rosenwald, Christian Berdel, Martin Maisenhoelder, Ofer Shpilberg, Josif Amam, Konstantinos Christofyllakis, Frank Hartmann, Niels Murawski, Stephan Stilgenbauer, Maike Nickelsen, Gerald Wulf, Bertram Glaß, Norbert Schmitz, Bettina Altmann, Markus Loeffler, Michael Pfreundschuh - The Lancet 2019 cited by 253

  10. Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

    Authors: Sandeep S. Davé, George W. Wright, Bruce K. Tan, Andreas Rosenwald, Randy D. Gascoyne, Wing C. Chan, Richard I. Fisher, Rita M. Braziel, Lisa M. Rimsza, Thomas M. Grogan, Thomas P. Miller, Michael LeBlanc, Timothy C. Greiner, Dennis D. Weisenburger, James C. Lynch, Julie M. Vose, Jamés O. Armitage, Erlend B. Smeland, Stein Kvaløy, Harald Holte, Jan Delabie, Joseph M. Connors, Peter M. Lansdorp, Qin Ouyang, T. Andrew Lister, Andrew Davies, A. J. Norton, H. K. Müller-Hermelink, German Ott, Elı́as Campo, Emilio Montserrat, Wyndham H. Wilson, Elaine S. Jaffe, Richard H. Simon, Liming Yang, John Powell, Hong Zhao, Neta Goldschmidt, Michael Chiorazzi, Louis M. Staudt - New England Journal of Medicine 2004 cited by 1,433

  11. Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01

    Authors: Francesco d’Amore, Thomas Relander, Grete F. Lauritzsen, Esa Jantunen, Hans Hagberg, Harald Anderson, Harald Holte, Anders Österborg, Mats Merup, Peter de Nully Brown, Outi Kuittinen, Martin Erlanson, Bjørn Østenstad, Unn-Merete Fagerli, Ole Gadeberg, Christer Sundström, Jan Delabie, Elisabeth Ralfkiær, Martine Vornanen, Helle Toldbod - Journal of Clinical Oncology 2012 cited by 590

  12. Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial

    Authors: Sari Riihijärvi, Idun Fiskvik, Mervi Taskinen, Heli Vajavaara, M. Tikkala, Olav Erich Yri, Marja‐Liisa Karjalainen‐Lindsberg, Jan Delabie, Erlend B. Smeland, Harald Holte, Sirpa Leppä - Haematologica 2014 cited by 114

  13. Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis

    Authors: Massimo Federico, María Dolores Caballero Barrigón, Luigi Marcheselli, Vittoria Tarantino, Martina Manni, Clémentine Sarkozy, Sara Alonso, Mariëlle J. Wondergem, Guillaume Cartron, Armando López‐Guillermo, Djamila E. Issa, Franck Morschhauser, Miguel Alcoceba, Eva Kimby, Chiara Rusconi, Martine E.D. Chamuleau, Harald Holte, Sandra Lockmer, Silvia Montoto, María Gomes da Silva, Igor Aurer, Emanuele Zucca, Ewa Paszkiewicz‐Kozik, Carla Minoia, Tetiana Skrypets, Yngvild Nuvin Blaker, Gilles Salles, Bertrand Coiffier - The Lancet Haematology 2018 cited by 116

  14. Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion

    Authors: Michael Bishop, Richard T. Maziarz, Edmund K. Waller, Ulrich Jäger, Jason R. Westin, Joseph P. McGuirk, Isabelle Fleury, Harald Holte, Peter Borchmann, Christopher del Corral, Ranjan Tiwari, Özlem Anak, Rakesh Awasthi, Lida Pacaud, Vadim Romanov, Stephen J. Schuster - Blood Advances 2019 cited by 86

  15. Molecular Diagnosis of Burkitt's Lymphoma

    Authors: Sandeep S. Davé, Kai Fu, George W. Wright, Lloyd T. Lam, Philip M. Kluin, Evert-Jan Boerma, Timothy C. Greiner, Dennis D. Weisenburger, Andreas Rosenwald, German Ott, Hans-Konrad Müller-Hermelink, Randy D. Gascoyne, Jan Delabie, Lisa M. Rimsza, Rita M. Braziel, Thomas M. Grogan, Elı́as Campo, Elaine S. Jaffe, Bhavana J. Davé, Warren G. Sanger, Martin Bast, Julie M. Vose, Jamés O. Armitage, Joseph M. Connors, Erlend B. Smeland, Stein Kvaløy, Harald Holte, Richard I. Fisher, Thomas P. Miller, Emilio Montserrat, Wyndham H. Wilson, Manisha Bahl, Hong Zhao, Liming Yang, John Powell, Richard Simon, Wing C. Chan, Louis M. Staudt - New England Journal of Medicine 2006 cited by 903

  16. TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma

    Authors: Sarah E. Josefsson, Klaus Beiske, Yngvild Nuvin Blaker, Mette Førsund, Harald Holte, Bjørn Østenstad, Eva Kimby, Hakan Köksal, Sébastien Wälchli, Baoyan Bai, Erlend B. Smeland, Ronald Levy, Arne Kolstad, Kanutte Huse, June H. Myklebust - Cancer Immunology Research 2019 cited by 115

  17. Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma

    Authors: Richard T. Maziarz, Edmund K. Waller, Ulrich Jaeger, Isabelle Fleury, Joseph P. McGuirk, Harald Holte, Samantha Jaglowski, Stephen J. Schuster, Michael Bishop, Jason R. Westin, Stephan Mielke, Takanori Teshima, Veronika Bachanová, S.R. Foley, Peter Borchmann, Gilles Salles, Jie Zhang, Ranjan Tiwari, Lida Pacaud, Qiufei Ma, Constantine S. Tam - Blood Advances 2020 cited by 82

  18. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

    Authors: Andreas Rosenwald, George W. Wright, Adrian Wiestner, Wing C. Chan, Joseph M. Connors, Elı́as Campo, Randy D. Gascoyne, Thomas M. Grogan, H. K. Müller-Hermelink, Erlend B. Smeland, Michael Chiorazzi, Jena M. Giltnane, Elaine M. Hurt, Hong Zhao, Lauren Averett, Sarah E. Henrickson, Liming Yang, John Powell, Wyndham H. Wilson, Elaine S. Jaffe, Richard Simon, Richard D. Klausner, Emilio Montserrat, Francesc Bosch, Timothy C. Greiner, Dennis D. Weisenburger, Warren G. Sanger, Bhavana J. Davé, James C. Lynch, Julie M. Vose, Jamés O. Armitage, Richard I. Fisher, Thomas P. Miller, Michael LeBlanc, German Ott, Stein Kvaløy, Harald Holte, Jan Delabie, Louis M. Staudt - Cancer Cell 2003 cited by 927

  19. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project

    Authors: Jan Delabie, Harald Holte, Julie M. Vose, Fred Ullrich, Elaine S. Jaffe, Kerry J. Savage, Joseph M. Connors, Lisa M. Rimsza, Nancy L. Harris, Konrad Müller-Hermelink, Thomas Rüdiger, Bertrand Coiffier, Randy D. Gascoyne, Françoise Berger, Kensei Tobinai, Wing Y. Au, Raymond Liang, Emili Montserrat, Ephraim P. Hochberg, Stefano Pileri, Massimo Federico, Bharat N. Nathwani, Jamés O. Armitage, Dennis D. Weisenburger - Blood 2011 cited by 360

  20. Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival

    Authors: Adrian Wiestner, Mahsa Tehrani, Michael Chiorazzi, George W. Wright, Federica Gibellini, Kazutaka Nakayama, Hui Liu, Andreas Rosenwald, Hans Konrad Müller‐Hermelink, German Ott, Wing C. Chan, Timothy C. Greiner, Dennis D. Weisenburger, Julie M. Vose, Jamés O. Armitage, Randy D. Gascoyne, Joseph M. Connors, Elı́as Campo, Emilio Montserrat, Francesc Bosch, Erlend B. Smeland, Stein Kvaløy, Harald Holte, Jan Delabie, Richard I. Fisher, Thomas M. Grogan, Thomas P. Miller, Wyndham H. Wilson, Elaine S. Jaffe, Louis M. Staudt - Blood 2007 cited by 252

  21. Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma

    Authors: Hakan Köksal, Pierre Dillard, Sarah E. Josefsson, Sólrún Melkorka Maggadóttir, Sylvie Pollmann, Anne Fåne, Yngvild Nuvin Blaker, Klaus Beiske, Kanutte Huse, Arne Kolstad, Harald Holte, Gunnar Kvalheim, Erlend B. Smeland, June H. Myklebust, Else Marit Inderberg, Sébastien Wälchli - Blood Advances 2019 cited by 62

  22. Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis

    Authors: Sirpa Leppä, Judit Jørgensen, Anne Tierens, Leo Meriranta, Ingunn Østlie, Peter de Nully Brown, Unn‐Merete Fagerli, Thomas Stauffer Larsen, Susanna Mannisto, Lars Munksgaard, Martin Maisenhölder, Kaija Vasala, Peter Meyer, Mats Jerkeman, Magnus Björkholm, Øystein Fluge, Sirkku Jyrkkiö, Knut Liestøl, Elisabeth Ralfkiær, Signe Spetalen, Klaus Beiske, Marja‐Liisa Karjalainen‐Lindsberg, Harald Holte - Blood Advances 2020 cited by 58

  23. Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

    Authors: Andreas Rosenwald, George W. Wright, Karen Leroy, Xin Yu, Philippe Gaulard, Randy D. Gascoyne, Wing C. Chan, Tong Zhao, Corinne Haïoun, Timothy C. Greiner, Dennis D. Weisenburger, James C. Lynch, Julie M. Vose, Jamés O. Armitage, Erlend B. Smeland, Stein Kvaløy, Harald Holte, Jan Delabie, Elı́as Campo, Emili Montserrat, Armando López‐Guillermo, German Ott, Hans Konrad Müller‐Hermelink, Joseph M. Connors, Rita M. Braziel, Thomas M. Grogan, Richard I. Fisher, Thomas P. Miller, Michael LeBlanc, Michael Chiorazzi, Hong Zhao, Liming Yang, John Powell, Wyndham H. Wilson, Elaine S. Jaffe, Richard Simon, Richard D. Klausner, Louis M. Staudt - The Journal of Experimental Medicine 2003 cited by 1,101

  24. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project

    Authors: Dennis D. Weisenburger, Kerry J. Savage, Nancy L. Harris, Randy D. Gascoyne, Elaine S. Jaffe, Kenneth MacLennan, Thomas Rüdiger, Stefano Pileri, Shigeo Nakamura, Bharat N. Nathwani, Elı́as Campo, Françoise Berger, Bertrand Coiffier, Won-Seog Kim, Harald Holte, Massimo Federico, Wing Y. Au, Kensei Tobinai, Jamés O. Armitage, Julie M. Vose, for the International Peripheral T-cell Lymphoma Project - Blood 2011 cited by 429